Maintaining cognitive health in elderly women

Aging Health

Volumn 5, Issue 5, 2009, Pages 655-670

  Clifford, Angela ^a   Udechuku, Amina Yesufu ^a   Edwards, Louisa ^a   Bandelow, Stephan ^a   Hogervorst, Eef ^a  

^a Brockington Building ^*  (United Kingdom)

Author keywords

Caffeine; Cardiovascular risk; Dementia; Estrogen; Exercise; Thyroid hormones

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; ESTRADIOL; ESTROGEN; FOLIC ACID; PHYTOESTROGEN; PLACEBO; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; THYROID HORMONE; THYROTROPIN; TRACE ELEMENT;

AEROBIC EXERCISE; AGE; AGED; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COFFEE; COGNITION; COGNITIVE DEFECT; DEMENTIA; DETERIORATION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRINKING BEHAVIOR; EARLY MENOPAUSE; ELDERLY CARE; ESTROGEN THERAPY; FEMALE; FITNESS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; LONG TERM CARE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; REVIEW; SEX DIFFERENCE; SMOKING; SYMPTOM;

EID: 70450173422     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/ahe.09.65     Document Type: Review

References (122)

1. Poon LW: Assessing neuropsychological changes in pharmacological trials. Clin. Neuropharmacol 16(Suppl. 1), S31-S38 (1993).
2. American Psychiatric Association: Diagnostic and Statistical Manual of mental disorders (4th edition) (DSM-IV) American Psychiatric Association (1994).
3. McKhann G, Drachman D, Folstein M et al.: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34(7), 939-944 (1984). • Key article on the diagnostic criteria for Alzheimer's disease. (Pubitemid 14076461)
4. Wimo A, von Strauss E, Nordberg G, Sassi F, Johansson L: Time spent on informal and formal care giving for persons with dementia in Sweden. Health Policy 61(3), 255-268 (2002). • Key article on costs of dementia worldwide.
5. Nelson PT, Braak H, Markesbery WR: Neuropathology and cognitive impairment in Alzheimer's disease: a complex but coherent relationship. J. Neuropathol. Exp. Neurol. 68(1), 1-14 (2009).
6. Launer LJ, Hofman A: Studies on the incidence of dementia: the European perspective. Neuroepidemiology 11(3), 127-134 (1992).
7. Fratiglioni L, Viitanen M, von Strauss E et al.: Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen project, Stockholm. Neurology 48(1), 132-138 (1997). (Pubitemid 27039531)
8. Nagy Z, Esiri MM, Joachim C et al.: Comparison of pathological diagnostic criteria for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 12(3), 182-189 (1998). (Pubitemid 29154987)
9. Nagy Z, Esiri MM, Hindley NJ et al.: Accuracy of clinical operational diagnostic criteria for Alzheimer's disease in relation to different pathological diagnostic protocols. Dement. Geriatr. Cogn. Disord. 9(4), 219-226 (1998). (Pubitemid 28279616)
10. Hogervorst E, Barnetson L, Jobst KA et al.: Diagnosing dementia: interrater reliability assessment and accuracy of the NINCDS/ADRDA criteria versus CERAD histopathological criteria for Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 11(2), 107-113 (2000). (Pubitemid 30114092)
11. Petersen RC, Smith GE, Waring SC et al.: Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56(3), 303-308 (1999). • Key article describing mild cognitive impairment, a risk factor for Alzheimer's disease.
12. Schrijnemaekers AM, de Jager CA, Hogervorst E, Budge MM: Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls. J. Clin. Exp. Neuropsychol. 28(3), 438-455 (2006).
13. Kivipelto M, Ngandu T, Fratiglioni L et al.: Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch. Neurol. 62(10), 1556-1560 (2005). • Important article showing cumulative risk of cardiovascular risk factors for dementia.
14. Launer LJ, Ross GW, Petrovitch H et al.: Midlife blood pressure and dementia: the Honolulu-Asia Aging Study. Neurobiol. Aging 21(1), 49-55 (2000). (Pubitemid 30224785)
15. Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA: Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement. Geriatr. Cogn. Disord. 28(1), 75-80 (2009).
16. Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J, Yaffe K: Body mass index in midlife and risk of Alzheimer's disease and vascular dementia. Curr. Alzheimer Res. 4(2), 103-109 (2007). (Pubitemid 46557496)
17. Dahl A, Hassing LB, Fransson E et al.: Being overweight in midlife is associated with lower cognitive ability and steeper cognitive decline in late life. J. Gerontol. A Biol. Sci. Med. Sci. DOI: 10.1093/gerona/glp035 (2009).
18. Qiu C, Winblad B, Fratiglioni L: The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 4(8), 487-499 (2005). (Pubitemid 40982459)
19. Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD: Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer's disease. Arch. Neurol. 59(5), 787-793 (2002). (Pubitemid 34517761)
20. Skoog I, Gustafson D: Update on hypertension and Alzheimer's disease. Neurol. Res. 28(6), 605-611 (2006). • Good article demonstrating how blood pressure changes in response to dementia onset.
21. West NA, Haan MN: Body adiposity in late life and risk of dementia or cognitive impairment in a longitudinal community-based study. J. Gerontol. A Biol. Sci. Med. Sci. 64A(1), 103-109 (2009).
22. McGuinness B, Craig D, Bullock R, Passmore P: Statins for the prevention of dementia. Cochrane Database Syst. Rev. (4), CD003160 (2008).
23. McGuinness B, Todd S, Passmore P, Bullock R: Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst. Rev. (2), CD004034 (2006).
24. Kivipelto M, Rovio S, Ngandu T et al.: Apolipoprotein E en4 magnifies lifestyle risks for dementia: a population-based study. J. Cell. Mol. Med. 12(6B), 2762-2771 (2008).
25. Reitz C, den Heijer T, van Duijn C, Hofman A, Breteler MM: Relation between smoking and risk of dementia and Alzheimer's disease: the rotterdam study. Neurology 69(10), 998-1005 (2007). (Pubitemid 47366053)
26. Mukamal KJ, Kuller LH, Fitzpatrick AL et al.: Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 289(11), 1405-1413 (2003).
27. Geleijnse JM: Habitual coffee consumption and blood pressure: an epidemiological perspective. Vasc. Health Risk Manag. 4(5), 963-970 (2008).
28. Hameleers PA, Van Boxtel MP, Hogervorst E et al.: Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups. Hum. Psychopharmacol. 15(8), 573-581 (2000). (Pubitemid 32121113)
29. Hogervorst E, Riedel WJ, Schmitt JAJ, Jolles J: Caffeine improves memory performance during distraction in middle-aged, but not in young or old subjects. Hum. Psychopharmacol. 13(4), 277-284 (1998). (Pubitemid 28294935)
30. Schmitt JA, Hogervorst E, Vuurman EF, Jolles J, Riedel WJ: Memory functions and focussed attention in middle-aged and elderly subjects are unaffected by a low, acute dose of caffeine. J. Nutr. Health Aging 7(5), 301-303 (2003). (Pubitemid 36944238)
31. Hogervorst E, Sadjimim T, Yesufu A, Kreager P, Rahardjo TB: High tofu intake is associated with worse memory in elderly Indonesian men and women. Dement. Geriatr. Cogn. Disord. 26(1), 50-57 (2008). • First article describing differential associations of different soy products with cognition.
32. van Praag H, Christie BR, Sejnowski TJ, Gage FH: Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc. Natl Acad. Sci. USA 96(23), 13427-13431 (1999).
33. Rombouts SA, Barkhof F, Witter MP, Scheltens P: Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci. Lett. 285(3), 231-233 (2000). (Pubitemid 30252070)
34. Diana RA, Yonelinas AP, Ranganath C: Imaging recollection and familiarity in the medial temporal lobe: a three-component model. Trends Cogn. Sci. 11(9), 379-386 (2007).
35. Etnier JL, Salazar W, Landers DM et al.: The influence of physical fitness and exercise upon cognitive functioning: a meta-analysis. J. Sport Exerc. Psychol. 19(3), 249 (1997). (Pubitemid 127119047)
36. Querido JS, Sheel AW: Regulation of cerebral blood flow during exercise. Sports Med. 37(9), 765-782 (2007).
37. Di Paola M, Caltagirone C, Fadda L et al.: Hippocampal atrophy is the critical brain change in patients with hypoxic amnesia. Hippocampus 18(7), 719-728 (2008). (Pubitemid 352032397)
38. Churchill JD, Galvez R, Colcombe S et al.: Exercise, experience and the aging brain. Neurobiol. Aging 23(5), 941-955 (2002).
39. Eggermont L, Swaab D, Luiten P, Scherder E: Exercise, cognition and Alzheimer's disease: more is not necessarily better. Neurosci. Biobehav. Rev. 30(4), 562-575 (2006).
40. Rovio S, Kareholt I, Helkala EL et al.: Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol. 4(11), 705-711 (2005). (Pubitemid 41434560)
41. Andel R, Crowe M, Pedersen NL, Fratiglioni L, Johansson B, Gatz M: Physical exercise at midlife and risk of dementia three decades later: a population-based study of Swedish twins. J. Gerontol. A Biol. Sci. Med. Sci. 63(1), 62-66 (2008). (Pubitemid 351738465)
42. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K: Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch. Neurol. 58(3), 498-504 (2001). (Pubitemid 32217469)
43. Sumic A, Michael YL, Carlson NE, Howieson DB, Kaye JA: Physical activity and the risk of dementia in oldest old. J. Aging Health 19(2), 242-259 (2007). (Pubitemid 46548382)
44. Ho SC, Woo J, Sham A, Chan SG, Yu AL: A 3-year follow-up study of social, lifestyle and health predictors of cognitive impairment in a Chinese older cohort. Int. J. Epidemiol. 30(6), 1389-1396 (2001). (Pubitemid 34134296)
45. Abbott RD, White LR, Ross GW, Masaki KH, Curb JD, Petrovitch H: Walking and dementia in physically capable elderly men. JAMA 292(12), 1447-1453 (2004).
46. Wang HX, Karp A, Winblad B, Fratiglioni L: Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project. Am. J. Epidemiol. 155(12), 1081-1087 (2002). (Pubitemid 34625496)
47. Lautenschlager NT, Cox KL, Flicker L et al.: Effect of physical activity on cognitive function in older adults at risk for Alzheimer's disease: a randomized trial. JAMA 300(9), 1027-1037 (2008).
48. van Uffelen JG, Chinapaw MJ, van Mechelen W, Hopman-Rock M: Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. Br. J. Sports Med. 42(5), 344-351 (2008).
49. Arcoverde C, Deslandes A, Rangel A et al.: Role of physical activity on the maintenance of cognition and activities of daily living in elderly with Alzheimer's disease. Arq. Neuropsiquiatr. 66(2B), 323-327 (2008). (Pubitemid 352030275)
50. Clifford AH, Bandelow S, Hogervorst E: The effects of physical exercise on cognitive function in the elderly: a review. In: Handbook of Cognitive Aging: Causes, Processes and Effects. Gariepy Q, Menard R (Eds). Nova Publishers, NY, USA (2009) (In press).
51. van Boxtel MP, Paas FG, Houx PJ et al.: Aerobic capacity and cognitive performance in a cross-sectional aging study. Med. Sci. Sports Exerc. 29(10), 1357-1365 (1997).
52. Deeny SP, Poeppel D, Zimmerman JB et al.: Exercise, APOE, and working memory: MEG and behavioral evidence for benefit of exercise in APOE e4 carriers. Biol. Psychol. 78(2), 179-187 (2008).
53. Tsutsumi T, Don BM, Zaichkowsky LD, Delizonna LL: Physical fitness and psychological benefits of strength training in community dwelling older adults. Appl. Human Sci. 16(6), 257-266 (1997).
54. Cassilhas RC, Viana VA, Grassmann V et al.: The impact of resistance exercise on the cognitive function of the elderly. Med. Sci. Sports Exerc. 39(8), 1401-1407 (2007). (Pubitemid 47344023)
55. Fabre C, Masse-Biron J, Chamari K et al.: Evaluation of quality of life in elderly healthy subjects after aerobic and/or mental training. Arch. Gerontol. Geriatr. 28(1), 9-22 (1999). (Pubitemid 28546710)
56. Perrig-Chiello P, Perrig WJ, Ehrsam R, Staehelin HB, Krings F: The effects of resistance training on well-being and memory in elderly volunteers. Age Ageing 27(4), 469-475 (1998). (Pubitemid 28404611)
57. Chodzko-Zajko WJ: Physical fitness, cognitive performance, and aging. Med. Sci. Sports Exerc. 23(7), 868-872 (1991).
58. Hawkins HL, Kramer AF, Capaldi D: Aging, exercise, and attention. Psychol. Aging 7(4), 643-653 (1992).
59. Hall CD, Smith AL, Keele SW: The impact of aerobic activity on cognitive function in older adults: a new synthesis based on the concept of executive control. Eur. J. Cogn. Psychol. 13(1/2), 279 (2001).
60. Colcombe S, Kramer AF: Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol. Sci. 14(2), 125-130 (2003). (Pubitemid 38146974)
61. Huppert FA: Age-related changes in memory: Learning and remembering new information. In: Handbook of Neuropsychology. Boller F, Grafman J (Eds). Elseilvier Science, Amsterdam, The Netherlands (1991).
62. Colcombe SJ, Kramer AF, Erickson KI et al.: Cardiovascular fitness, cortical plasticity, and aging. Proc. Natl Acad. Sci. USA 101(9), 3316-3321 (2004).
63. Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L: Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst. Rev. (3), CD005381 (2008). (Pubitemid 351807407)
64. Lachman ME, Neupert SD, Bertrand R, Jette AM: The effects of strength training on memory in older adults. J. Aging Phys. Act. 14(1), 59-73 (2006). (Pubitemid 43036727)
65. Brinton RD, Nilsen J: Effects of estrogen plus progestin on risk of dementia. JAMA 290(13), 1706; author reply 1707-1708 (2003). • Describes why estrogens have negative effects on brain cells undergoing pathological change.
66. Shkurnikov MU, Donnikov AE, Akimov EB, Sakharov DA, Tonevitsky AG: Free testosterone as marker of adaptation to medium-intensive exercise. Bull. Exp. Biol. Med. 146(3), 354-357 (2008).
67. Barrett-Connor E, Goodman-Gruen D, Patay B: Endogenous sex hormones and cognitive function in older men. J. Clin. Endocrinol. Metab. 84(10), 3681-3685 (1999). (Pubitemid 30645225)
68. Berchtold NC, Kesslak JP, Pike CJ, Adlard PA, Cotman CW: Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus. Eur. J. Neurosci. 14(12), 1992-2002 (2001).
69. Erickson KI, Colcombe SJ, Elavsky S et al.: Interactive effects of fitness and hormone treatment on brain health in postmenopausal women. Neurobiol. Aging 28(2), 179-185 (2007). (Pubitemid 44894626)
70. Hogervorst E: The short-lived effects of HRT on cognitive function. Invited review. In: Effects of Estrogen on Brain Function. Rasgun NL (Ed.). John Hopkins University Press, Baltimore, MD, USA 46-78 (2006).
71. Yesufu A, Bandelow S, Hogervorst E: Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women. Womens Health, 3(2), 173-194 (2007). (Pubitemid 46488180)
72. Henderson VW, Guthrie JR, Dudley EC, Burger HG, Dennerstein L: Estrogen exposures and memory at midlife: a population-based study of women. Neurology 60(8), 1369-1371 (2003).
73. Greendale GA, Huang MH, Wight RG et al.: Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology 72(21), 1850-1857 (2009).
74. Thilers PP, MacDonald SW, Nilsson LG, Herlitz A: Accelerated postmenopausal cognitive decline is restricted to women with normal BMI: longitudinal evidence from the Betula project. the association between steroid hormones and cognitive performance in adulthood. PhD thesis: Karolinska Institute, Stockholm, Sweden (2009).
75. Fuh JL, Wang SJ, Lee SJ, Lu SR, Juang KD: A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas 53(4), 447-453 (2006).
76. Sherwin BB: Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13(4), 345-357 (1988).
77. Nappi RE, Sinforiani E, Mauri M, Bono G, Polatti F, Nappi G: Memory functioning at menopause: impact of age in ovariectomized women. Gynecol. Obstet. Invest. 47(1), 29-36 (1999). (Pubitemid 29026892)
78. Rocca WA, Bower JH, Maraganore DM et al.: Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69(11), 1074-1083 (2007).
79. LeBlanc ES, Janowsky J, Chan BK, Nelson HD: Hormone replacement therapy and cognition: Systematic review and meta-analysis. JAMA 285(11), 1489-1499 (2001). (Pubitemid 32221898)
80. Polo-Kantola P, Portin R, Koskinen T, Polo O, Irjala K, Erkkola R: Climacteric symptoms do not impair cognitive performances in postmenopausal women. Maturitas 27(1), 13-23 (1997). (Pubitemid 27230293)
81. Wolf OT, Kudielka BM, Hellhammer DH et al.: Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: verbal memory changes are associated with the treatment induced estradiol levels. Psychoneuroendocrinology 24(7), 727-741 (1999).
82. Ditkoff EC, Crary WG, Cristo M, Lobo RA: Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet. Gynecol. 78(6), 991-995 (1991).
83. McEwen BS, Alves SE, Bulloch K, Weiland NG: Ovarian steroids and the brain: implications for cognition and aging. Neurology 48(5 Suppl. 7), S8-S15 (1997). (Pubitemid 27230087)
84. Morrison JH, Hof PR: Life and death of neurons in the aging cerebral cortex. Int. Rev. Neurobiol. 81, 41-57 (2007).
85. Langenberg P, Kjerulff KH, Stolley PD: Hormone replacement and menopausal symptoms following hysterectomy. Am. J. Epidemiol. 146(10), 870-880 (1997). (Pubitemid 27498104)
86. Hogervorst E, Williams J, Budge M, Riedel W, Jolles J: The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 101(3), 485-512 (2000). • This review was cited over 200 times by other authors in 2009. (Pubitemid 30953107)
87. Hogervorst E, Bandelow S, Moffat SD: Increasing testosterone levels and effects on cognitive functions in elderly men and women: a review. Curr. Drug Targets CNS Neurol. Disord. 4(5), 531-540 (2005).
88. Sarrel PM: Ovarian hormones and the circulation. Maturitas 12(3), 287-298 (1990).
89. Rossouw JE, Prentice RL, Manson JE et al.: Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297(13), 1465-1477 (2007).
90. Harman SM, Brinton EA, Cedars M et al.: KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric 8(1), 3-12 (2005). (Pubitemid 40675116)
91. Kritz-Silverstein D, Barrett-Connor E: Hysterectomy, oophorectomy, and cognitive function in older women. J. Am. Geriatr. Soc. 50(1), 55-61 (2002). (Pubitemid 34053023)
92. File SE, Heard JE, Rymer J: Trough oestradiol levels associated with cognitive impairment in post-menopausal women after 10 years of oestradiol implants. Psychopharmacology 161(1), 107-112 (2002).
93. Henderson VW, Paganini-Hill A, Miller BL et al.: Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54(2), 295-301 (2000). (Pubitemid 30078056)
94. Wang PN, Liao SQ, Liu RS et al.: Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology 54(11), 2061-2066 (2000).
95. Hogervorst E, Henderson V, Brinton-Diaz R, Gibbs R: Hormones Cognition and Dementia. Cambridge University Press, UK (2009). • This book is commissioned by Cambridge University Press and published in October, giving the state of the art of recent hormone and cognition research from a wide variety of research perspectives.
96. Mulnard RA, Cotman CW, Kawas C et al.: Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's disease cooperative study. JAMA 283(8), 1007-1015 (2000).
97. Shumaker SA, Legault C, Rapp SR et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative memory study: a randomized controlled trial. JAMA 289(20), 2651-2662 (2003). (Pubitemid 37430136)
98. Shumaker SA, Legault C, Kuller L et al.: Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative memory study. JAMA 291(24), 2947-2958 (2004). • Both references [97] and [98] had a huge impact on hormone use as these papers suggested an increased risk in dementia with hormone treatment. (Pubitemid 38802684)
99. Studd J: Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60. Climacteric 12(3), 206-209 (2009).
100. Hogervorst E, Huppert F, Matthews FE, Brayne C: Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology 33(7), 1013-1022 (2008).
101. Breteler MM, van Duijn CM, Chandra V et al.: Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM risk factors research group. Int. J. Epidemiol. 20(Suppl. 2), S36-S42 (1991).
102. van Osch LA, Hogervorst E, Combrinck M, Smith AD: Low thyroid-stimulating hormone as an independent risk factor for Alzheimer's disease. Neurology 62(11), 1967-1971 (2004).
103. Gomez JM: Serum leptin, insulin-like growth factor-I components and sex-hormone binding globulin relationship with sex, age and body composition in healthy population. Protein Pept. Lett. 14(7), 708-711 (2007).
104. Ho KK; 2007 GH Deficiency Consensus Workshop Participants: Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH research society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Edocrinology, Japanese Endocrine Society, and the Endocrine Society of Australia. Eur. J. Endocrinol. 157(6), 695-700 (2007).
105. Hogervorst E, Bandelow S: Should surgical menopausal women be treated with estrogens to decrease the risk of dementia? Neurology 69(11), 1070-1071 (2007). (Pubitemid 47517550)
106. Zhao L, Brinton RD: WHI and WHIMS follow-up and human studies of soy isoflavones on cognition. Expert Rev. Neurother. 7(11), 1549-1564 (2007). • This excellent review gives a good overview of the state of the art in phytoestrogen and cognition/dementia research from a broad perspective.
107. Gleason CE, Carlsson CM, Barnet JH et al.: A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women. Age Ageing 38(1), 86-93 (2009).
108. White LR, Petrovitch H, Ross GW et al.: Brain aging and midlife tofu consumption. J. Am. Coll. Nutr. 19(2), 242-255 (2000). (Pubitemid 30185357)
109. Rice MM, Graves AB, McCurry SM et al.: Tofu consumption and cognition in older Japanese American men and women. Proceedings of the Third International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, 31 October-3 November 1999, Washington, DC, USA 130 676S (2000).
110. Hogervorst E, Yesufu A, Sadjimim T, Kreager P, Rahardjo TB: Different forms of soy processing may determine the positive or negative impact on cognitive function of Indonesian elderly. In: Hormones, Cognition and Dementia. Hogervorst E, Henderson AS, Brinton-Diaz R, Gibbs R (Eds). Cambridge University Press, UK (2009).
111. Huang MH, Luetters C, Buckwalter GJ et al.: Dietary genistein intake and cognitive performance in a multiethnic cohort of midlife women. Menopause (New York NY), 13(4), 621-630 (2006). (Pubitemid 44079532)
112. Kreijkamp-Kaspers S, Kok L, Grobbee DE et al.: Dietary phytoestrogen intake and cognitive function in older women. J. Gerontol. A Biol. Sci. Med. Sci. 62(5), 556-562 (2007). (Pubitemid 47065696)
113. Wang H, Murphy PA: Isoflavone content in commercial soybean products. J. Agric. Food Chem. 42, 1666-1673 (1994).
114. Ginting E, Arcot J: High-performance liquid chromatographic determination of naturally occurring folates during tempe preparation. J. Agric. Food Chem. 52(26), 7752-7758 (2004). (Pubitemid 40053650)
115. Hogervorst E, Smith AD: The interaction of serum folate and estradiol levels in Alzheimer's disease. Neuro Endocrinol. Lett. 23(2), 155-160 (2002).
116. Smith AD: The worldwide challenge of the dementias: a role for B vitamins and homocysteine? Food Nutr. Bull. 29(Suppl. 2), S143-S172 (2008).
117. Durga J, van Boxtel MP, Schouten EG et al.: Effect of 3 year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 369(9557), 208-216 (2007). (Pubitemid 46107683)
118. Malouf M, Grimley EJ, Areosa SA: Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst. Rev. (4)(4), CD004514 (20030.
119. Dangour AD, Sibson VL, Fletcher AE: Micronutrient supplementation in later life: limited evidence for benefit. J. Gerontol. A Biol. Sci. Med. Sci. 59(7), 659-673 (2004).
120. Feart C, Samieri C, Rondeau V et al.: Adherence to a mediterranean diet, cognitive decline, and risk of dementia. JAMA 302(6), 638-648 (2009).
121. Scarmeas N, Luchsinger JA, Schupf N et al.: Physical activity, diet, and risk of Alzheimer disease. JAMA 302(6), 627-637 (2009).
122. Lee L, Kang SA, Lee HO et al.: Relationships between dietary intake and cognitive function level in Korean elderly people. Public health (133-138) (2001). (Pubitemid 32266415)